A randomized trial evaluating virus-specific effects of a combination probiotic in children with acute

Stephen B Freedman1, Jianling Xie2, Alberto Nettel-Aguirre2

  • 1Alberta Children's Hospital Foundation Professor in Child Health and Wellness, Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, 28 Oki Drive NW, Calgary, AB, T3B 6A8, Canada. Stephen.freedman@ahs.ca.

Insights

This study found that probiotics containing Lactobacillus rhamnosus and Lactobacillus helveticus did not speed up diarrhea recovery in children with acute gastroenteritis. The findings suggest probiotics are not routinely recommended for young children with stomach infections.

Area of Science:

  • Pediatrics
  • Microbiology
  • Gastroenterology

Background:

  • Gastroenteritis causes significant childhood mortality globally.
  • Probiotics are often suggested to shorten diarrhea duration, but recent evidence is conflicting.
  • Changes in common gastroenteritis pathogens, possibly due to vaccination, may affect probiotic efficacy.

Purpose of the Study:

  • To evaluate the efficacy of a specific probiotic in treating acute gastroenteritis in children.
  • To determine if the probiotic reduces symptom duration or viral shedding.
  • To investigate potential virus-specific effects of the probiotic.

Main Methods:

  • A multi-center, double-blind, placebo-controlled trial.
  • 816 children with acute gastroenteritis were randomized to receive probiotics or placebo.
  • Clinical outcomes and viral nucleic acid in stool were monitored for 28 days.

Main Results:

  • No significant difference in clinical symptom resolution between probiotic and placebo groups.
  • The probiotic did not enhance viral nucleic acid clearance from stool.
  • No virus-specific benefits were observed.

Conclusions:

  • The studied probiotic (Lactobacillus rhamnosus and Lactobacillus helveticus) did not demonstrate efficacy in treating acute gastroenteritis in children.
  • Data do not support the routine use of this probiotic for pediatric gastroenteritis.
  • Further research may be needed to understand the evolving role of probiotics in pediatric infectious diseases.

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
524
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
363
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
909
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
841
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
3.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
827